Stay updated with breaking news from Ann Burrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) CFO Terry-Ann Burrell sold 2,454 shares of the company’s stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $30.31, for a total value of $74,380.74. Following the sale, the chief financial officer now owns 49,303 shares of the company’s stock, […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) CFO Terry-Ann Burrell sold 2,454 shares of the business’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $30.31, for a total value of $74,380.74. Following the completion of the transaction, the chief financial officer now owns 49,303 […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 13,910,000 shares, an increase of 11.5% from the February 28th total of 12,480,000 shares. Based on an average trading volume of 908,500 shares, the days-to-cover ratio is […]
Should You Buy or Sell Beam Therapeutics Stock? Get The Latest BEAM Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Sanford C. Bernstein assumed coverage on shares of Beam Therapeutics (NASDAQ:BEAM – Get Rating) in a research note released on Tuesday, The Fly reports. The firm issued a market perform rating and a $37.00 target price on the stock. Several other equities analysts also recently weighed in on the company. BMO Capital Markets raised Beam […]